Breaking News

Over a month ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Initiation
Viking Therapeutics initiated with an Outperform at BMO Capital » 16:14
06/04/20
06/04
16:14
06/04/20
16:14
VKTX

Viking Therapeutics

$7.13 /

+0.005 (+0.07%)

BMO Capital analyst…

BMO Capital analyst Matthew Luchini initiated coverage of Viking Therapeutics with an Outperform rating and $14 price target. Viking's lead drug, VK2809, has shown "early but encouraging" proof-of-concept and presents an attractive potential option for the treatment of non-alcoholic steatohepatitis, or NASH, Luchini tells investors. He sees the drug having the potential for "best-in-class" reduction in liver fat along with a positive impact on markers of cardiovascular disease, the analyst added.

ShowHide Related Items >><<
VKTX Viking Therapeutics
$7.13 /

+0.005 (+0.07%)

VKTX Viking Therapeutics
$7.13 /

+0.005 (+0.07%)

05/05/20 Chardan
Viking Therapeutics initiated with a Buy at Chardan
05/04/20 B. Riley FBR
Viking Therapeutics price target lowered to $12 from $16 at B. Riley FBR
05/01/20 BTIG
Viking Therapeutics initiated with a Buy at BTIG
02/27/20 H.C. Wainwright
Viking Therapeutics price target lowered to $18 from $31 at H.C. Wainwright
VKTX Viking Therapeutics
$7.13 /

+0.005 (+0.07%)

VKTX Viking Therapeutics
$7.13 /

+0.005 (+0.07%)

Conference/Events
UBS to hold a virtual conference » 04:55
05/20/20
05/20
04:55
05/20/20
04:55
RDHL

RedHill Biopharma

$7.19 /

+0.28 (+4.05%)

, ANGO

AngioDynamics

$11.05 /

+0.11 (+1.01%)

, CDXS

Codexis

$11.15 /

-0.42 (-3.63%)

, AHCO

AdaptHealth

$16.68 /

+0.18 (+1.09%)

, APLT

Applied Therapeutics

$47.53 /

+2.41 (+5.34%)

, TFX

Teleflex

$346.33 /

-6.665 (-1.89%)

, UHS

Universal Health

$101.01 /

+0.55 (+0.55%)

, HRC

Hill-Rom

$98.94 /

-2.17 (-2.15%)

, NVRO

Nevro

$122.31 /

+0.47 (+0.39%)

, AMED

Amedisys

$190.01 /

-2.98 (-1.54%)

, ESTA

Establishment Labs

$16.25 /

-0.86 (-5.03%)

, HUM

Humana

$395.51 /

+4.41 (+1.13%)

, VKTX

Viking Therapeutics

$7.05 /

-0.09 (-1.26%)

, WST

West Pharmaceutical

$211.46 /

-7.14 (-3.27%)

Global Healthcare Virtual…

Global Healthcare Virtual Conference will be held on May 18-20.

ShowHide Related Items >><<
WST West Pharmaceutical
$211.46 /

-7.14 (-3.27%)

VKTX Viking Therapeutics
$7.05 /

-0.09 (-1.26%)

UHS Universal Health
$101.01 /

+0.55 (+0.55%)

TFX Teleflex
$346.33 /

-6.665 (-1.89%)

RDHL RedHill Biopharma
$7.19 /

+0.28 (+4.05%)

NVRO Nevro
$122.31 /

+0.47 (+0.39%)

HUM Humana
$395.51 /

+4.41 (+1.13%)

HRC Hill-Rom
$98.94 /

-2.17 (-2.15%)

ESTA Establishment Labs
$16.25 /

-0.86 (-5.03%)

CDXS Codexis
$11.15 /

-0.42 (-3.63%)

APLT Applied Therapeutics
$47.53 /

+2.41 (+5.34%)

ANGO AngioDynamics
$11.05 /

+0.11 (+1.01%)

AMED Amedisys
$190.01 /

-2.98 (-1.54%)

AHCO AdaptHealth
$16.68 /

+0.18 (+1.09%)

RDHL RedHill Biopharma
$7.19 /

+0.28 (+4.05%)

02/27/20 Roth Capital
RedHill Biopharma price target lowered to $15 from $20.25 at Roth Capital
07/12/19 WBB Securities
RedHill Biopharma upgraded to Strong Buy from Buy at WBB Securities
ANGO AngioDynamics
$11.05 /

+0.11 (+1.01%)

04/08/20
Fly Intel: Top five analyst downgrades
04/08/20 KeyBanc
AngioDynamics downgraded to Sector Weight from Overweight at KeyBanc
04/07/20 KeyBanc
AngioDynamics downgraded to Sector Weight from Overweight at KeyBanc
12/30/19 Stifel
Avanos makes 'welcome addition' with 'highly experienced' CFO, says Stifel
CDXS Codexis
$11.15 /

-0.42 (-3.63%)

03/10/20 Benchmark
Codexis initiated with a Buy at Benchmark
AHCO AdaptHealth
$16.68 /

+0.18 (+1.09%)

02/28/20 Deutsche Bank
AdaptHealth price target raised to $19 from $12 at Deutsche Bank
01/31/20
Fly Intel: Top five analyst initiations
01/30/20 Stifel
AdaptHealth initiated with a Buy at Stifel
01/07/20 Jefferies
Jefferies starts AdaptHealth at Buy with $15 price target
APLT Applied Therapeutics
$47.53 /

+2.41 (+5.34%)

04/22/20
Fly Intel: Top five analyst initiations
04/22/20 Goldman Sachs
Applied Therapeutics initiated with a Buy at Goldman Sachs
02/27/20 Barclays
Applied Therapeutics initiated with an Overweight at Barclays
02/27/20 Barclays
Applied Therapeutics initiated with an Overweight at Barclays
TFX Teleflex
$346.33 /

-6.665 (-1.89%)

05/01/20 Piper Sandler
Teleflex price target lowered to $375 from $425 at Piper Sandler
04/03/20 Raymond James
Teleflex price target lowered to $360 from $450 at Raymond James
02/20/20 Piper Sandler
Teleflex price target raised to $425 from $400 at Piper Sandler
12/12/19 Wells Fargo
SeaSpine, Glaukos double-downgraded to Underweight at Wells Fargo
UHS Universal Health
$101.01 /

+0.55 (+0.55%)

04/29/20 Deutsche Bank
Universal Health price target lowered to $135 from $165 at Deutsche Bank
04/28/20 Citi
Universal Health price target lowered to $128 from $157 at Citi
03/26/20 JPMorgan
Channel checks suggest hospital total revenues down 40%-60%, says JPMorgan
03/23/20 BofA
Universal Health downgraded to Neutral on Vegas recession risk at BofA
HRC Hill-Rom
$98.94 /

-2.17 (-2.15%)

03/17/20 Barclays
Hill-Rom upgraded to Overweight from Equal Weight at Barclays
12/17/19 Morgan Stanley
Hill-Rom upgraded to Overweight on accelerating momentum at Morgan Stanley
12/17/19 Morgan Stanley
Hill-Rom upgraded to Overweight from Equal Weight at Morgan Stanley
06/27/19 Raymond James
Hill-Rom's DoD contract win a 'nice development,' says Raymond James
NVRO Nevro
$122.31 /

+0.47 (+0.39%)

05/06/20 Citi
Nevro price target raised to $137 from $130 at Citi
04/02/20 SunTrust
Nevro price target lowered to $120 from $146 at SunTrust
04/02/20 Wells Fargo
Nevro price target lowered to $126 from $158 at Wells Fargo
03/04/20 Citi
Nevro initiated with a Buy at Citi
AMED Amedisys
$190.01 /

-2.98 (-1.54%)

05/11/20 Raymond James
Amedisys price target lowered to $210 from $225 at Raymond James
05/07/20 Benchmark
Amedisys downgraded to Hold on limited near-term visibility at Benchmark
05/07/20 Benchmark
Amedisys downgraded to Hold from Buy at Benchmark
03/09/20 Benchmark
Benchmark upgrades Amedisys to Buy on Home Health boost from crowded hospitals
ESTA Establishment Labs
$16.25 /

-0.86 (-5.03%)

05/14/20
Fly Intel: Top five analyst initiations
05/14/20 Goldman Sachs
Establishment Labs initiated with a Neutral at Goldman Sachs
01/03/20 BTIG
Zimmer Biomet, Staar Surgical, ViewRay among top 2020 picks at BTIG
07/24/19 Wells Fargo
Allergan recall to benefit Establishment and Sientra, says Wells Fargo
HUM Humana
$395.51 /

+4.41 (+1.13%)

05/04/20 Mizuho
Humana price target raised to $420 from $405 at Mizuho
04/30/20 Credit Suisse
Humana price target raised to $423 from $400 at Credit Suisse
04/30/20 Oppenheimer
Humana price target raised to $425 from $400 at Oppenheimer
04/29/20 Cantor Fitzgerald
Humana comments on telephonic sales 'positive' for eHealth, says Cantor
VKTX Viking Therapeutics
$7.05 /

-0.09 (-1.26%)

05/05/20 Chardan
Viking Therapeutics initiated with a Buy at Chardan
05/04/20 B. Riley FBR
Viking Therapeutics price target lowered to $12 from $16 at B. Riley FBR
05/01/20 BTIG
Viking Therapeutics initiated with a Buy at BTIG
02/27/20 H.C. Wainwright
Viking Therapeutics price target lowered to $18 from $31 at H.C. Wainwright
WST West Pharmaceutical
$211.46 /

-7.14 (-3.27%)

04/24/20 BofA
West Pharmaceutical upgraded to Neutral from Underperform at BofA
04/24/20 BofA
West Pharmaceutical upgraded to Neutral from Underperform at BofA
12/12/19
Fly Intel: Top five analyst downgrades
12/12/19 BofA
West Pharmaceutical downgraded to Underperform from Neutral at BofA/Merrill
WST West Pharmaceutical
$211.46 /

-7.14 (-3.27%)

VKTX Viking Therapeutics
$7.05 /

-0.09 (-1.26%)

UHS Universal Health
$101.01 /

+0.55 (+0.55%)

TFX Teleflex
$346.33 /

-6.665 (-1.89%)

RDHL RedHill Biopharma
$7.19 /

+0.28 (+4.05%)

NVRO Nevro
$122.31 /

+0.47 (+0.39%)

HUM Humana
$395.51 /

+4.41 (+1.13%)

HRC Hill-Rom
$98.94 /

-2.17 (-2.15%)

ESTA Establishment Labs
$16.25 /

-0.86 (-5.03%)

CDXS Codexis
$11.15 /

-0.42 (-3.63%)

APLT Applied Therapeutics
$47.53 /

+2.41 (+5.34%)

ANGO AngioDynamics
$11.05 /

+0.11 (+1.01%)

AMED Amedisys
$190.01 /

-2.98 (-1.54%)

AHCO AdaptHealth
$16.68 /

+0.18 (+1.09%)

UHS Universal Health
$101.01 /

+0.55 (+0.55%)

HUM Humana
$395.51 /

+4.41 (+1.13%)

VKTX Viking Therapeutics
$7.05 /

-0.09 (-1.26%)

UHS Universal Health
$101.01 /

+0.55 (+0.55%)

NVRO Nevro
$122.31 /

+0.47 (+0.39%)

HUM Humana
$395.51 /

+4.41 (+1.13%)

APLT Applied Therapeutics
$47.53 /

+2.41 (+5.34%)

ANGO AngioDynamics
$11.05 /

+0.11 (+1.01%)

VKTX Viking Therapeutics
$7.05 /

-0.09 (-1.26%)

HUM Humana
$395.51 /

+4.41 (+1.13%)

Conference/Events
UBS to hold a virtual conference » 04:55
05/19/20
05/19
04:55
05/19/20
04:55
RDHL

RedHill Biopharma

$6.91 /

+0.18 (+2.67%)

, ANGO

AngioDynamics

$10.94 /

+0.93 (+9.29%)

, CDXS

Codexis

$11.57 /

+0.47 (+4.23%)

, AHCO

AdaptHealth

$16.50 /

+0.21 (+1.29%)

, APLT

Applied Therapeutics

$45.12 /

+1.22 (+2.78%)

, TFX

Teleflex

$353.00 /

+18.395 (+5.50%)

, UHS

Universal Health

$100.46 /

+7.86 (+8.49%)

, HRC

Hill-Rom

$101.11 /

+1.3 (+1.30%)

, NVRO

Nevro

$121.84 /

+4.09 (+3.47%)

, AMED

Amedisys

$192.99 /

+8.12 (+4.39%)

, ESTA

Establishment Labs

$17.11 /

+0.71 (+4.33%)

, HUM

Humana

$391.10 /

-7.25 (-1.82%)

, VKTX

Viking Therapeutics

$7.14 /

+0.04 (+0.56%)

, WST

West Pharmaceutical

$218.60 /

+4.73 (+2.21%)

Global Healthcare Virtual…

Global Healthcare Virtual Conference will be held on May 18-20.

ShowHide Related Items >><<
WST West Pharmaceutical
$218.60 /

+4.73 (+2.21%)

VKTX Viking Therapeutics
$7.14 /

+0.04 (+0.56%)

UHS Universal Health
$100.46 /

+7.86 (+8.49%)

TFX Teleflex
$353.00 /

+18.395 (+5.50%)

RDHL RedHill Biopharma
$6.91 /

+0.18 (+2.67%)

NVRO Nevro
$121.84 /

+4.09 (+3.47%)

HUM Humana
$391.10 /

-7.25 (-1.82%)

HRC Hill-Rom
$101.11 /

+1.3 (+1.30%)

ESTA Establishment Labs
$17.11 /

+0.71 (+4.33%)

CDXS Codexis
$11.57 /

+0.47 (+4.23%)

APLT Applied Therapeutics
$45.12 /

+1.22 (+2.78%)

ANGO AngioDynamics
$10.94 /

+0.93 (+9.29%)

AMED Amedisys
$192.99 /

+8.12 (+4.39%)

AHCO AdaptHealth
$16.50 /

+0.21 (+1.29%)

RDHL RedHill Biopharma
$6.91 /

+0.18 (+2.67%)

02/27/20 Roth Capital
RedHill Biopharma price target lowered to $15 from $20.25 at Roth Capital
07/12/19 WBB Securities
RedHill Biopharma upgraded to Strong Buy from Buy at WBB Securities
ANGO AngioDynamics
$10.94 /

+0.93 (+9.29%)

04/08/20
Fly Intel: Top five analyst downgrades
04/08/20 KeyBanc
AngioDynamics downgraded to Sector Weight from Overweight at KeyBanc
04/07/20 KeyBanc
AngioDynamics downgraded to Sector Weight from Overweight at KeyBanc
12/30/19 Stifel
Avanos makes 'welcome addition' with 'highly experienced' CFO, says Stifel
CDXS Codexis
$11.57 /

+0.47 (+4.23%)

03/10/20 Benchmark
Codexis initiated with a Buy at Benchmark
AHCO AdaptHealth
$16.50 /

+0.21 (+1.29%)

02/28/20 Deutsche Bank
AdaptHealth price target raised to $19 from $12 at Deutsche Bank
01/31/20
Fly Intel: Top five analyst initiations
01/30/20 Stifel
AdaptHealth initiated with a Buy at Stifel
01/07/20 Jefferies
Jefferies starts AdaptHealth at Buy with $15 price target
APLT Applied Therapeutics
$45.12 /

+1.22 (+2.78%)

04/22/20
Fly Intel: Top five analyst initiations
04/22/20 Goldman Sachs
Applied Therapeutics initiated with a Buy at Goldman Sachs
02/27/20 Barclays
Applied Therapeutics initiated with an Overweight at Barclays
02/27/20 Barclays
Applied Therapeutics initiated with an Overweight at Barclays
TFX Teleflex
$353.00 /

+18.395 (+5.50%)

05/01/20 Piper Sandler
Teleflex price target lowered to $375 from $425 at Piper Sandler
04/03/20 Raymond James
Teleflex price target lowered to $360 from $450 at Raymond James
02/20/20 Piper Sandler
Teleflex price target raised to $425 from $400 at Piper Sandler
12/12/19 Wells Fargo
SeaSpine, Glaukos double-downgraded to Underweight at Wells Fargo
UHS Universal Health
$100.46 /

+7.86 (+8.49%)

04/29/20 Deutsche Bank
Universal Health price target lowered to $135 from $165 at Deutsche Bank
04/28/20 Citi
Universal Health price target lowered to $128 from $157 at Citi
03/26/20 JPMorgan
Channel checks suggest hospital total revenues down 40%-60%, says JPMorgan
03/23/20 BofA
Universal Health downgraded to Neutral on Vegas recession risk at BofA
HRC Hill-Rom
$101.11 /

+1.3 (+1.30%)

03/17/20 Barclays
Hill-Rom upgraded to Overweight from Equal Weight at Barclays
12/17/19 Morgan Stanley
Hill-Rom upgraded to Overweight on accelerating momentum at Morgan Stanley
12/17/19 Morgan Stanley
Hill-Rom upgraded to Overweight from Equal Weight at Morgan Stanley
06/27/19 Raymond James
Hill-Rom's DoD contract win a 'nice development,' says Raymond James
NVRO Nevro
$121.84 /

+4.09 (+3.47%)

05/06/20 Citi
Nevro price target raised to $137 from $130 at Citi
04/02/20 SunTrust
Nevro price target lowered to $120 from $146 at SunTrust
04/02/20 Wells Fargo
Nevro price target lowered to $126 from $158 at Wells Fargo
03/04/20 Citi
Nevro initiated with a Buy at Citi
AMED Amedisys
$192.99 /

+8.12 (+4.39%)

05/11/20 Raymond James
Amedisys price target lowered to $210 from $225 at Raymond James
05/07/20 Benchmark
Amedisys downgraded to Hold on limited near-term visibility at Benchmark
05/07/20 Benchmark
Amedisys downgraded to Hold from Buy at Benchmark
03/09/20 Benchmark
Benchmark upgrades Amedisys to Buy on Home Health boost from crowded hospitals
ESTA Establishment Labs
$17.11 /

+0.71 (+4.33%)

05/14/20
Fly Intel: Top five analyst initiations
05/14/20 Goldman Sachs
Establishment Labs initiated with a Neutral at Goldman Sachs
01/03/20 BTIG
Zimmer Biomet, Staar Surgical, ViewRay among top 2020 picks at BTIG
07/24/19 Wells Fargo
Allergan recall to benefit Establishment and Sientra, says Wells Fargo
HUM Humana
$391.10 /

-7.25 (-1.82%)

05/04/20 Mizuho
Humana price target raised to $420 from $405 at Mizuho
04/30/20 Credit Suisse
Humana price target raised to $423 from $400 at Credit Suisse
04/30/20 Oppenheimer
Humana price target raised to $425 from $400 at Oppenheimer
04/29/20 Cantor Fitzgerald
Humana comments on telephonic sales 'positive' for eHealth, says Cantor
VKTX Viking Therapeutics
$7.14 /

+0.04 (+0.56%)

05/05/20 Chardan
Viking Therapeutics initiated with a Buy at Chardan
05/04/20 B. Riley FBR
Viking Therapeutics price target lowered to $12 from $16 at B. Riley FBR
05/01/20 BTIG
Viking Therapeutics initiated with a Buy at BTIG
02/27/20 H.C. Wainwright
Viking Therapeutics price target lowered to $18 from $31 at H.C. Wainwright
WST West Pharmaceutical
$218.60 /

+4.73 (+2.21%)

04/24/20 BofA
West Pharmaceutical upgraded to Neutral from Underperform at BofA
04/24/20 BofA
West Pharmaceutical upgraded to Neutral from Underperform at BofA
12/12/19
Fly Intel: Top five analyst downgrades
12/12/19 BofA
West Pharmaceutical downgraded to Underperform from Neutral at BofA/Merrill
WST West Pharmaceutical
$218.60 /

+4.73 (+2.21%)

VKTX Viking Therapeutics
$7.14 /

+0.04 (+0.56%)

UHS Universal Health
$100.46 /

+7.86 (+8.49%)

TFX Teleflex
$353.00 /

+18.395 (+5.50%)

RDHL RedHill Biopharma
$6.91 /

+0.18 (+2.67%)

NVRO Nevro
$121.84 /

+4.09 (+3.47%)

HUM Humana
$391.10 /

-7.25 (-1.82%)

HRC Hill-Rom
$101.11 /

+1.3 (+1.30%)

ESTA Establishment Labs
$17.11 /

+0.71 (+4.33%)

CDXS Codexis
$11.57 /

+0.47 (+4.23%)

APLT Applied Therapeutics
$45.12 /

+1.22 (+2.78%)

ANGO AngioDynamics
$10.94 /

+0.93 (+9.29%)

AMED Amedisys
$192.99 /

+8.12 (+4.39%)

AHCO AdaptHealth
$16.50 /

+0.21 (+1.29%)

UHS Universal Health
$100.46 /

+7.86 (+8.49%)

HUM Humana
$391.10 /

-7.25 (-1.82%)

VKTX Viking Therapeutics
$7.14 /

+0.04 (+0.56%)

UHS Universal Health
$100.46 /

+7.86 (+8.49%)

NVRO Nevro
$121.84 /

+4.09 (+3.47%)

HUM Humana
$391.10 /

-7.25 (-1.82%)

APLT Applied Therapeutics
$45.12 /

+1.22 (+2.78%)

ANGO AngioDynamics
$10.94 /

+0.93 (+9.29%)

VKTX Viking Therapeutics
$7.14 /

+0.04 (+0.56%)

HUM Humana
$391.10 /

-7.25 (-1.82%)

Conference/Events
UBS to hold a virtual conference » 08:53
05/18/20
05/18
08:53
05/18/20
08:53
RDHL

RedHill Biopharma

$6.73 /

-0.11 (-1.61%)

, ANGO

AngioDynamics

$10.01 /

+0.01 (+0.10%)

, CDXS

Codexis

$11.10 /

+0.35 (+3.26%)

, AHCO

AdaptHealth

$16.29 /

-0.11 (-0.67%)

, APLT

Applied Therapeutics

$43.90 /

+0.85 (+1.97%)

, TFX

Teleflex

$334.60 /

+1.41 (+0.42%)

, UHS

Universal Health

$92.60 /

+1.13 (+1.24%)

, HRC

Hill-Rom

$99.81 /

+0.4 (+0.40%)

, NVRO

Nevro

$117.75 /

-2.27 (-1.89%)

, AMED

Amedisys

$184.87 /

+7.66 (+4.32%)

, ESTA

Establishment Labs

$16.40 /

-0.91 (-5.26%)

, HUM

Humana

$398.35 /

+12.43 (+3.22%)

, VKTX

Viking Therapeutics

$7.10 /

+0.2 (+2.90%)

, WST

West Pharmaceutical

$213.87 /

+3.45 (+1.64%)

Global Healthcare Virtual…

Global Healthcare Virtual Conference will be held on May 18-20.

ShowHide Related Items >><<
WST West Pharmaceutical
$213.87 /

+3.45 (+1.64%)

VKTX Viking Therapeutics
$7.10 /

+0.2 (+2.90%)

UHS Universal Health
$92.60 /

+1.13 (+1.24%)

TFX Teleflex
$334.60 /

+1.41 (+0.42%)

RDHL RedHill Biopharma
$6.73 /

-0.11 (-1.61%)

NVRO Nevro
$117.75 /

-2.27 (-1.89%)

HUM Humana
$398.35 /

+12.43 (+3.22%)

HRC Hill-Rom
$99.81 /

+0.4 (+0.40%)

ESTA Establishment Labs
$16.40 /

-0.91 (-5.26%)

CDXS Codexis
$11.10 /

+0.35 (+3.26%)

APLT Applied Therapeutics
$43.90 /

+0.85 (+1.97%)

ANGO AngioDynamics
$10.01 /

+0.01 (+0.10%)

AMED Amedisys
$184.87 /

+7.66 (+4.32%)

AHCO AdaptHealth
$16.29 /

-0.11 (-0.67%)

RDHL RedHill Biopharma
$6.73 /

-0.11 (-1.61%)

02/27/20 Roth Capital
RedHill Biopharma price target lowered to $15 from $20.25 at Roth Capital
07/12/19 WBB Securities
RedHill Biopharma upgraded to Strong Buy from Buy at WBB Securities
ANGO AngioDynamics
$10.01 /

+0.01 (+0.10%)

04/08/20
Fly Intel: Top five analyst downgrades
04/08/20 KeyBanc
AngioDynamics downgraded to Sector Weight from Overweight at KeyBanc
04/07/20 KeyBanc
AngioDynamics downgraded to Sector Weight from Overweight at KeyBanc
12/30/19 Stifel
Avanos makes 'welcome addition' with 'highly experienced' CFO, says Stifel
CDXS Codexis
$11.10 /

+0.35 (+3.26%)

03/10/20 Benchmark
Codexis initiated with a Buy at Benchmark
AHCO AdaptHealth
$16.29 /

-0.11 (-0.67%)

02/28/20 Deutsche Bank
AdaptHealth price target raised to $19 from $12 at Deutsche Bank
01/31/20
Fly Intel: Top five analyst initiations
01/30/20 Stifel
AdaptHealth initiated with a Buy at Stifel
01/07/20 Jefferies
Jefferies starts AdaptHealth at Buy with $15 price target
APLT Applied Therapeutics
$43.90 /

+0.85 (+1.97%)

04/22/20
Fly Intel: Top five analyst initiations
04/22/20 Goldman Sachs
Applied Therapeutics initiated with a Buy at Goldman Sachs
02/27/20 Barclays
Applied Therapeutics initiated with an Overweight at Barclays
02/27/20 Barclays
Applied Therapeutics initiated with an Overweight at Barclays
TFX Teleflex
$334.60 /

+1.41 (+0.42%)

05/01/20 Piper Sandler
Teleflex price target lowered to $375 from $425 at Piper Sandler
04/03/20 Raymond James
Teleflex price target lowered to $360 from $450 at Raymond James
02/20/20 Piper Sandler
Teleflex price target raised to $425 from $400 at Piper Sandler
12/12/19 Wells Fargo
SeaSpine, Glaukos double-downgraded to Underweight at Wells Fargo
UHS Universal Health
$92.60 /

+1.13 (+1.24%)

04/29/20 Deutsche Bank
Universal Health price target lowered to $135 from $165 at Deutsche Bank
04/28/20 Citi
Universal Health price target lowered to $128 from $157 at Citi
03/26/20 JPMorgan
Channel checks suggest hospital total revenues down 40%-60%, says JPMorgan
03/23/20 BofA
Universal Health downgraded to Neutral on Vegas recession risk at BofA
HRC Hill-Rom
$99.81 /

+0.4 (+0.40%)

03/17/20 Barclays
Hill-Rom upgraded to Overweight from Equal Weight at Barclays
12/17/19 Morgan Stanley
Hill-Rom upgraded to Overweight on accelerating momentum at Morgan Stanley
12/17/19 Morgan Stanley
Hill-Rom upgraded to Overweight from Equal Weight at Morgan Stanley
06/27/19 Raymond James
Hill-Rom's DoD contract win a 'nice development,' says Raymond James
NVRO Nevro
$117.75 /

-2.27 (-1.89%)

05/06/20 Citi
Nevro price target raised to $137 from $130 at Citi
04/02/20 SunTrust
Nevro price target lowered to $120 from $146 at SunTrust
04/02/20 Wells Fargo
Nevro price target lowered to $126 from $158 at Wells Fargo
03/04/20 Citi
Nevro initiated with a Buy at Citi
AMED Amedisys
$184.87 /

+7.66 (+4.32%)

05/11/20 Raymond James
Amedisys price target lowered to $210 from $225 at Raymond James
05/07/20 Benchmark
Amedisys downgraded to Hold on limited near-term visibility at Benchmark
05/07/20 Benchmark
Amedisys downgraded to Hold from Buy at Benchmark
03/09/20 Benchmark
Benchmark upgrades Amedisys to Buy on Home Health boost from crowded hospitals
ESTA Establishment Labs
$16.40 /

-0.91 (-5.26%)

05/14/20
Fly Intel: Top five analyst initiations
05/14/20 Goldman Sachs
Establishment Labs initiated with a Neutral at Goldman Sachs
01/03/20 BTIG
Zimmer Biomet, Staar Surgical, ViewRay among top 2020 picks at BTIG
07/24/19 Wells Fargo
Allergan recall to benefit Establishment and Sientra, says Wells Fargo
HUM Humana
$398.35 /

+12.43 (+3.22%)

05/04/20 Mizuho
Humana price target raised to $420 from $405 at Mizuho
04/30/20 Credit Suisse
Humana price target raised to $423 from $400 at Credit Suisse
04/30/20 Oppenheimer
Humana price target raised to $425 from $400 at Oppenheimer
04/29/20 Cantor Fitzgerald
Humana comments on telephonic sales 'positive' for eHealth, says Cantor
VKTX Viking Therapeutics
$7.10 /

+0.2 (+2.90%)

05/05/20 Chardan
Viking Therapeutics initiated with a Buy at Chardan
05/04/20 B. Riley FBR
Viking Therapeutics price target lowered to $12 from $16 at B. Riley FBR
05/01/20 BTIG
Viking Therapeutics initiated with a Buy at BTIG
02/27/20 H.C. Wainwright
Viking Therapeutics price target lowered to $18 from $31 at H.C. Wainwright
WST West Pharmaceutical
$213.87 /

+3.45 (+1.64%)

04/24/20 BofA
West Pharmaceutical upgraded to Neutral from Underperform at BofA
04/24/20 BofA
West Pharmaceutical upgraded to Neutral from Underperform at BofA
12/12/19
Fly Intel: Top five analyst downgrades
12/12/19 BofA
West Pharmaceutical downgraded to Underperform from Neutral at BofA/Merrill
WST West Pharmaceutical
$213.87 /

+3.45 (+1.64%)

VKTX Viking Therapeutics
$7.10 /

+0.2 (+2.90%)

UHS Universal Health
$92.60 /

+1.13 (+1.24%)

TFX Teleflex
$334.60 /

+1.41 (+0.42%)

RDHL RedHill Biopharma
$6.73 /

-0.11 (-1.61%)

NVRO Nevro
$117.75 /

-2.27 (-1.89%)

HUM Humana
$398.35 /

+12.43 (+3.22%)

HRC Hill-Rom
$99.81 /

+0.4 (+0.40%)

ESTA Establishment Labs
$16.40 /

-0.91 (-5.26%)

CDXS Codexis
$11.10 /

+0.35 (+3.26%)

APLT Applied Therapeutics
$43.90 /

+0.85 (+1.97%)

ANGO AngioDynamics
$10.01 /

+0.01 (+0.10%)

AMED Amedisys
$184.87 /

+7.66 (+4.32%)

AHCO AdaptHealth
$16.29 /

-0.11 (-0.67%)

UHS Universal Health
$92.60 /

+1.13 (+1.24%)

HUM Humana
$398.35 /

+12.43 (+3.22%)

VKTX Viking Therapeutics
$7.10 /

+0.2 (+2.90%)

UHS Universal Health
$92.60 /

+1.13 (+1.24%)

NVRO Nevro
$117.75 /

-2.27 (-1.89%)

HUM Humana
$398.35 /

+12.43 (+3.22%)

APLT Applied Therapeutics
$43.90 /

+0.85 (+1.97%)

ANGO AngioDynamics
$10.01 /

+0.01 (+0.10%)

AMED Amedisys
$184.87 /

+7.66 (+4.32%)

VKTX Viking Therapeutics
$7.10 /

+0.2 (+2.90%)

HUM Humana
$398.35 /

+12.43 (+3.22%)

On The Fly
Novo Nordisk slips as analysts discuss NASH data, read-through to peers » 14:46
05/06/20
05/06
14:46
05/06/20
14:46
NVO

Novo Nordisk

$62.47 /

-0.81 (-1.28%)

, ICPT

Intercept

$89.74 /

+9.16 (+11.37%)

, NGM

NGM Biopharmaceuticals

$19.99 /

+2.06 (+11.49%)

, GNFT

Genfit

$21.09 /

-0.85 (-3.87%)

, ALT

Altimmune

$3.02 /

-0.11 (-3.51%)

, AKRO

Akero Therapeutics

$20.95 /

+0.27 (+1.31%)

, BMY

Bristol-Myers

$61.48 /

+0.13 (+0.21%)

, MDGL

Madrigal Pharmaceuticals

$88.54 /

-0.01 (-0.01%)

, VKTX

Viking Therapeutics

$6.64 /

-0.05 (-0.75%)

In conjunction with the…

Open Full Text

ShowHide Related Items >><<
NVO Novo Nordisk
$62.47 /

-0.81 (-1.28%)

05/06/20 Goldman Sachs
Goldman says Novo Nordisk NASH data a 'clear positive' for Intercept
05/06/20 Roth Capital
Novo data 'sets up the runway' for Altimmune, says Roth Capital
05/06/20 Stifel
Stifel says semaglutide data a 'slight positive' for NGM Biopharmaceuticals
05/04/20
Fly Intel: Top five analyst initiations
ICPT Intercept
$89.74 /

+9.16 (+11.37%)

04/02/20 Chardan
Intercept initiated with a Buy at Chardan
03/19/20 JMP Securities
JMP Securities says report on Intercept's OCA 'favorable'
NGM NGM Biopharmaceuticals
$19.99 /

+2.06 (+11.49%)

04/06/20 Raymond James
NGM Biopharmaceuticals initiated with a Strong Buy at Raymond James
03/31/20 H.C. Wainwright
Akero's BALANCED study results 'quite impressive,' says H.C. Wainwright
03/27/20 Citi
NGM Biopharmaceuticals price target lowered to $28 from $34 at Citi
GNFT Genfit
$21.09 /

-0.85 (-3.87%)

04/09/20 H.C. Wainwright
Genfit price target lowered to $46 from $58 at H.C. Wainwright
01/23/20 B. Riley FBR
Genfit selloff on data speculation unwarranted, says B. Riley FBR
ALT Altimmune
$3.02 /

-0.11 (-3.51%)

04/01/20
Roth Capital biotech analyst to hold an analyst/industry conference call
02/24/20
Fly Intel: Top five analyst initiations
AKRO Akero Therapeutics
$20.95 /

+0.27 (+1.31%)

03/02/20 H.C. Wainwright
Akero Therapeutics initiated with a Buy at H.C. Wainwright
02/13/20 Roth Capital
Akero Therapeutics price target raised to $43 from $34 at Roth Capital
02/10/20 Canaccord
Akero Therapeutics initiated with a Buy at Canaccord
BMY Bristol-Myers
$61.48 /

+0.13 (+0.21%)

04/20/20 Piper Sandler
Exelixis combo approval would increase kidney cancer use, says Piper Sandler
04/02/20
Fly Intel: Top five analyst upgrades
04/02/20 Morgan Stanley
Bristol-Myers upgraded to Overweight after pullback at Morgan Stanley
04/02/20 Morgan Stanley
Bristol-Myers upgraded to Overweight from Equal Weight at Morgan Stanley
MDGL Madrigal Pharmaceuticals
$88.54 /

-0.01 (-0.01%)

05/05/20 Chardan
Madrigal Pharmaceuticals initiated with a Buy at Chardan
03/05/20 Citi
Madrigal Pharmaceuticals price target lowered to $155 from $166 at Citi
VKTX Viking Therapeutics
$6.64 /

-0.05 (-0.75%)

05/05/20 Chardan
Viking Therapeutics initiated with a Buy at Chardan
05/04/20 B. Riley FBR
Viking Therapeutics price target lowered to $12 from $16 at B. Riley FBR
05/01/20 BTIG
Viking Therapeutics initiated with a Buy at BTIG
02/27/20 H.C. Wainwright
Viking Therapeutics price target lowered to $18 from $31 at H.C. Wainwright
Conference/Events
SunTrust to hold a virtual summit » 04:55
05/06/20
05/06
04:55
05/06/20
04:55
HOOK

Hookipa Pharma

$8.90 /

+0.45 (+5.33%)

, AXSM

Axsome Therapeutics

$90.35 /

-1.35 (-1.47%)

, VKTX

Viking Therapeutics

$6.69 /

+0.35 (+5.52%)

6th Annual Life Sciences…

6th Annual Life Sciences Virtual Summit 2020 will be held on May 5-6.

ShowHide Related Items >><<
HOOK Hookipa Pharma
$8.90 /

+0.45 (+5.33%)

09/27/19 H.C. Wainwright
Hookipa Pharma initiated with a Buy at H.C. Wainwright
05/13/19 BofA
Hookipa Pharma initiated with a Buy at BofA/Merrill
05/13/19 RBC Capital
Hookipa Pharma initiated with an Outperform at RBC Capital
AXSM Axsome Therapeutics
$90.35 /

-1.35 (-1.47%)

04/28/20 Guggenheim
Axsome Therapeutics price target raised to $200 from $158 at Guggenheim
04/28/20 SunTrust
Axsome Therapeutics price target raised to $200 from $145 at SunTrust
04/28/20 Cantor Fitzgerald
Axsome Therapeutics price target raised to $131 from $125 at Cantor Fitzgerald
04/28/20 H.C. Wainwright
Axsome Therapeutics price target raised to $210 from $200 at H.C. Wainwright
VKTX Viking Therapeutics
$6.69 /

+0.35 (+5.52%)

05/05/20 Chardan
Viking Therapeutics initiated with a Buy at Chardan
05/04/20 B. Riley FBR
Viking Therapeutics price target lowered to $12 from $16 at B. Riley FBR
05/01/20 BTIG
Viking Therapeutics initiated with a Buy at BTIG
02/27/20 H.C. Wainwright
Viking Therapeutics price target lowered to $18 from $31 at H.C. Wainwright
Conference/Events
SunTrust to hold a virtual summit » 08:55
05/05/20
05/05
08:55
05/05/20
08:55
HOOK

Hookipa Pharma

$8.45 /

+0.45 (+5.63%)

, AXSM

Axsome Therapeutics

$91.70 /

+1.6 (+1.78%)

, VKTX

Viking Therapeutics

$6.34 /

+0.91 (+16.76%)

6th Annual Life Sciences…

6th Annual Life Sciences Virtual Summit 2020 will be held on May 5-6.

ShowHide Related Items >><<
HOOK Hookipa Pharma
$8.45 /

+0.45 (+5.63%)

09/27/19 H.C. Wainwright
Hookipa Pharma initiated with a Buy at H.C. Wainwright
05/13/19 BofA
Hookipa Pharma initiated with a Buy at BofA/Merrill
05/13/19 RBC Capital
Hookipa Pharma initiated with an Outperform at RBC Capital
AXSM Axsome Therapeutics
$91.70 /

+1.6 (+1.78%)

04/28/20 Guggenheim
Axsome Therapeutics price target raised to $200 from $158 at Guggenheim
04/28/20 SunTrust
Axsome Therapeutics price target raised to $200 from $145 at SunTrust
04/28/20 Cantor Fitzgerald
Axsome Therapeutics price target raised to $131 from $125 at Cantor Fitzgerald
04/28/20 H.C. Wainwright
Axsome Therapeutics price target raised to $210 from $200 at H.C. Wainwright
VKTX Viking Therapeutics
$6.34 /

+0.91 (+16.76%)

05/05/20 Chardan
Viking Therapeutics initiated with a Buy at Chardan
05/04/20 B. Riley FBR
Viking Therapeutics price target lowered to $12 from $16 at B. Riley FBR
05/01/20 BTIG
Viking Therapeutics initiated with a Buy at BTIG
02/27/20 H.C. Wainwright
Viking Therapeutics price target lowered to $18 from $31 at H.C. Wainwright
Initiation
Viking Therapeutics initiated with a Buy at Chardan » 06:09
05/05/20
05/05
06:09
05/05/20
06:09
VKTX

Viking Therapeutics

$6.34 /

+0.91 (+16.76%)

Chardan initiated…

Chardan initiated coverage of Viking Therapeutics with a Buy rating and $15 price target.

ShowHide Related Items >><<
VKTX Viking Therapeutics
$6.34 /

+0.91 (+16.76%)

05/04/20 B. Riley FBR
Viking Therapeutics price target lowered to $12 from $16 at B. Riley FBR
05/01/20 BTIG
Viking Therapeutics initiated with a Buy at BTIG
02/27/20 H.C. Wainwright
Viking Therapeutics price target lowered to $18 from $31 at H.C. Wainwright
02/27/20 H.C. Wainwright
Viking Therapeutics price target lowered to $18 from $31 at H.C. Wainwright
Recommendations
Viking Therapeutics price target lowered to $12 from $16 at B. Riley FBR » 08:28
05/04/20
05/04
08:28
05/04/20
08:28
VKTX

Viking Therapeutics

$5.43 /

-0.33 (-5.73%)

B. Riley FBR analyst…

B. Riley FBR analyst Mayank Mamtani lowered the firm's price target on Viking Therapeutics to $12 from $16 and keeps a Buy rating on the shares. Continued delay in Phase IIb execution, originally investigational new drug application filing related and now COVID-19 related, has pressured the shares, which are down 28% year-to-date, Mamtani tells investors in a research note. The analyst now assumes a one-year delay in U.S. market entry, from 2024 to 2025. However, Mamtani anticipates a "substantial recovery," beginning in the second half of 2020 as Phase IIb VK2809 exposure increases in terms of patient number and length of therapy to address any safety-related concerns.

ShowHide Related Items >><<
VKTX Viking Therapeutics
$5.43 /

-0.33 (-5.73%)

05/01/20 BTIG
Viking Therapeutics initiated with a Buy at BTIG
02/27/20 H.C. Wainwright
Viking Therapeutics price target lowered to $18 from $31 at H.C. Wainwright
02/27/20 H.C. Wainwright
Viking Therapeutics price target lowered to $18 from $31 at H.C. Wainwright
11/21/19 SunTrust
Viking posting for VOYAGER includes 'nothing concerning,' says SunTrust
Initiation
Viking Therapeutics initiated with a Buy at BTIG » 05:44
05/01/20
05/01
05:44
05/01/20
05:44
VKTX

Viking Therapeutics

$5.76 /

-0.43 (-6.95%)

BTIG analyst Julian…

BTIG analyst Julian Harrison initiated coverage of Viking Therapeutics with a Buy rating and $9 price target. Within the TR beta space, VK2809 is positioned to be "best-in-class" with a favorable mix of potency and tolerability/safety, Harrison tells investors in a research note. The analyst believes VK2809's "strong" clinical data and Viking's enterprise value of only $140M as a chance for investors to invest in an "undervalued asset" ahead of "derisked" readouts.

ShowHide Related Items >><<
VKTX Viking Therapeutics
$5.76 /

-0.43 (-6.95%)

02/27/20 H.C. Wainwright
Viking Therapeutics price target lowered to $18 from $31 at H.C. Wainwright
02/27/20 H.C. Wainwright
Viking Therapeutics price target lowered to $18 from $31 at H.C. Wainwright
11/21/19 SunTrust
Viking posting for VOYAGER includes 'nothing concerning,' says SunTrust
07/15/19 Oppenheimer
Viking Therapeutics initiated with an Outperform at Oppenheimer

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.